2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution

被引:40
作者
Connolly, S
Aberg, A
Arvai, A
Beaton, HG
Cheshire, DR
Cook, AR
Cooper, S
Cox, D
Hamley, P
Mallinder, P
Millichip, I
Nicholls, DJ
Rosenfeld, RJ
St-Gallay, SA
Tainer, J
Tinker, AC
Wallace, AV
机构
[1] AstraZeneca R&D Charnwood, Dept Med Chem, Loughborough LE11 5RH, Leics, England
[2] AstraZeneca R&D Charnwood, Discovery BioSci Dept, Loughborough LE11 5RH, Leics, England
[3] AstraZeneca R&D Charnwood, Dept Mol Biol, Loughborough LE11 5RH, Leics, England
[4] AstraZeneca R&D Charnwood, Phys & Metab Sci Dept, Loughborough LE11 5RH, Leics, England
[5] AstraZeneca R&D, AstraZeneca Struct Chem Lab, S-43183 Molndal, Sweden
[6] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[7] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1021/jm031035n
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
4-Methylaminopyridine (4-MAP) (5) is a potent but nonselective nitric oxide synthase (NOS) inhibitor. While simple N-methylation in this series results in poor activity, more elaborate N-substitution such as with 4-piperidine carbamate or amide results in potent and selective inducible NOS inhibition. Evidently, a flipping of the pyridine ring between these new inhibitors allows the piperidine to interact with different residues and confer excellent selectivity.
引用
收藏
页码:3320 / 3323
页数:4
相关论文
共 17 条
[1]   Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[2]   3,4-dihydro-1-isoquinolinamines: A novel class of nitric oxide synthase inhibitors with a range of isoform selectivity and potency [J].
Beaton, H ;
Hamley, P ;
Nicholls, DJ ;
Tinker, AC ;
Wallace, AV .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (08) :1023-1026
[3]   Thienopyridines: Nitric oxide synthase inhibitors with potent in vivo activity [J].
Beaton, H ;
Boughton-Smith, N ;
Hamley, P ;
Ghelani, A ;
Nicholls, DJ ;
Tinker, AC ;
Wallace, AV .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (08) :1027-1030
[4]  
Boughton-Smith N K, 1998, IDrugs, V1, P321
[5]  
Cheshire D R, 2001, IDrugs, V4, P795
[6]   The structure of nitric oxide synthase oxygenase domain and inhibitor complexes [J].
Crane, BR ;
Arvai, AS ;
Gachhui, R ;
Wu, CQ ;
Ghosh, DK ;
Getzoff, ED ;
Stuehr, DJ ;
Tainer, JA .
SCIENCE, 1997, 278 (5337) :425-431
[7]   INDUCED RAW-264.7 MACROPHAGES EXPRESS SOLUBLE AND PARTICULATE NITRIC-OXIDE SYNTHASE - INHIBITION BY TRANSFORMING GROWTH-FACTOR-BETA [J].
FORSTERMANN, U ;
SCHMIDT, HHHW ;
KOHLHAAS, KL ;
MURAD, F .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 225 (02) :161-165
[8]   2-iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase [J].
Hagen, TJ ;
Bergmanis, AA ;
Kramer, SW ;
Fok, KF ;
Schmelzer, AE ;
Pitzele, BS ;
Swenton, L ;
Jerome, GM ;
Kornmeier, CM ;
Moore, WM ;
Branson, LF ;
Connor, JR ;
Manning, PT ;
Currie, MG ;
Hallinan, EA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (19) :3675-3683
[9]   Substituted 2-aminopyridines as inhibitors of nitric oxide synthases [J].
Hagmann, WH ;
Caldwell, CG ;
Chen, P ;
Durette, PL ;
Esser, CK ;
Lanza, TJ ;
Kopka, IE ;
Guthikonda, R ;
Shah, SK ;
MacCoss, M ;
Chabin, RM ;
Fletcher, D ;
Grant, SK ;
Green, BG ;
Humes, JL ;
Kelly, TM ;
Luell, S ;
Meurer, R ;
Moore, V ;
Pacholok, SG ;
Pavia, T ;
Williams, HR ;
Wong, KK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (17) :1975-1978
[10]   A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics [J].
Hansel, TT ;
Kharitonov, SA ;
Donnelly, LE ;
Erin, EM ;
Currie, MG ;
Moore, WM ;
Manning, PT ;
Recker, DP ;
Barnes, PJ .
FASEB JOURNAL, 2003, 17 (08) :1298-+